Bertrand Tombal

Papers

Total Citations

H-Index

About

Bertrand Tombal is a leading figure in urologic oncology, whose research has fundamentally reshaped the management of prostate cancer. His work spans the entire treatment continuum, from early-stage disease to advanced, castration-resistant prostate cancer (CRPC). A major contribution has been his leadership in pivotal clinical trials that established novel hormonal therapies as standard-of-care, demonstrating significant survival benefits for patients. His influential paper on maximizing outcomes across the genitourinary cancer treatment continuum, presented at the Interactive Genitourinary Cancer Conference, synthesized key controversies and helped guide clinical practice. With over 400 publications and an h-index exceeding 80, his work has garnered tens of thousands of citations, reflecting its profound impact. Notably, he has been instrumental in advancing the understanding of androgen receptor signaling and developing combination therapies that delay disease progression. As a Professor at the Université Catholique de Louvain and a frequent keynote speaker at international congresses, Tombal continues to drive innovation in personalized medicine for genitourinary cancers, making him a vital voice for both clinicians and researchers seeking to improve patient outcomes.